Endpoints News 2025年12月7日 #ASH25: Star Therapeutics details early data for blood disorder shot, weighs IPO
Endpoints News 2025年12月6日 #ASH25: AstraZeneca's dual-targeting CAR-T sees similar responses in Western patients as in China
Endpoints News 2025年12月6日 #ASH25: As one door closes for Regeneron’s lymphoma bispecific, another reopens
Endpoints News 2025年12月6日 Apple Tree Partners scores legal win against alleged holdout Russian investor
Endpoints News 2025年12月6日 ACIP vote, more FDA turnover; Introducing Endpoints Signal; ARCH, Parker Institute building next cancer bet; and more
Endpoints News 2025年12月6日 ORIC’s lung cancer pill shows promise in some settings but is dropped for HER2 mutations
Endpoints News 2025年12月5日 Denali drug hold; Intercept layoffs; Capital raises for Immatics, Capricor and Protara
Endpoints News 2025年12月5日 OTR Therapeutics gets $100M from Pfizer Ventures, others to build asset portfolio
Endpoints News 2025年12月5日 German court stops Merck from selling subcutaneous Keytruda in patent battle with Halozyme
Endpoints News 2025年12月5日 Ex-Intercept CEO takes over at Altimmune; Carolyn Bertozzi leaves Alnylam's board